January 6, 2016 – Virttu Biologics, a biopharmaceutical company pioneering the discovery and development of oncolytic viruses for treating cancer, today announced that Deirdre Gillespie MD, Chief Executive Officer, will present at the Biotech Showcase on Monday, January 11, 2016 in San Francisco. Dr Gillespie will discuss SEPREHVIRA , Virttu’s Phase 2 treatment for cancer, and next generation products.
